Global Radiopharmaceuticals Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Radiopharmaceuticals will have significant change from previous year. By the most conservative estimates of global Radiopharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5637 million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Radiopharmaceuticals market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Radiopharmaceuticals, covering the supply chain analysis, impact assessment to the Radiopharmaceuticals market size growth rate in several scenarios, and the measures to be undertaken by Radiopharmaceuticals companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Jubilant Pharma
Bayer
Nordion
Triad Isotopes
Mallinckrodt
GE Healthcare
Lantheus
China Isotope & Radiation
IBA Group
Eli Lilly
Dongcheng
SIEMENS
Navidea
Advanced Accelerator Applications
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Radiopharmaceuticals?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Radiopharmaceuticals Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals Consumption 2015-2025
2.1.2 Radiopharmaceuticals Consumption CAGR by Region
2.2 Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Radiopharmaceuticals Consumption by Type
2.3.1 Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
2.3.3 Global Radiopharmaceuticals Sale Price by Type (2015-2020)
2.4 Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceuticals Consumption by Application
2.5.1 Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.5.2 Global Radiopharmaceuticals Value and Market Share by Type (2015-2020)
2.5.3 Global Radiopharmaceuticals Sale Price by Type (2015-2020)
3 Global Radiopharmaceuticals by Company
3.1 Global Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Radiopharmaceuticals Sales by Company (2018-2020)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Company (2018-2020)
3.2 Global Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Radiopharmaceuticals Revenue by Company (2018-2020)
3.2.2 Global Radiopharmaceuticals Revenue Market Share by Company (2018-2020)
3.3 Global Radiopharmaceuticals Sale Price by Company
3.4 Global Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals by Regions
4.1 Radiopharmaceuticals by Regions
4.2 Americas Radiopharmaceuticals Consumption Growth
4.3 APAC Radiopharmaceuticals Consumption Growth
4.4 Europe Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Radiopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Radiopharmaceuticals Consumption by Countries (2015-2020)
5.1.2 Americas Radiopharmaceuticals Value by Countries (2015-2020)
5.2 Americas Radiopharmaceuticals Consumption by Type
5.3 Americas Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Radiopharmaceuticals Consumption by Regions
6.1.1 APAC Radiopharmaceuticals Consumption by Regions (2015-2020)
6.1.2 APAC Radiopharmaceuticals Value by Regions (2015-2020)
6.2 APAC Radiopharmaceuticals Consumption by Type
6.3 APAC Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Radiopharmaceuticals by Countries
7.1.1 Europe Radiopharmaceuticals Consumption by Countries (2015-2020)
7.1.2 Europe Radiopharmaceuticals Value by Countries (2015-2020)
7.2 Europe Radiopharmaceuticals Consumption by Type
7.3 Europe Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Radiopharmaceuticals Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Radiopharmaceuticals Value by Countries (2015-2020)
8.2 Middle East & Africa Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Radiopharmaceuticals Distributors
10.3 Radiopharmaceuticals Customer
11 Global Radiopharmaceuticals Market Forecast
11.1 Global Radiopharmaceuticals Consumption Forecast (2021-2025)
11.2 Global Radiopharmaceuticals Forecast by Regions
11.2.1 Global Radiopharmaceuticals Forecast by Regions (2021-2025)
11.2.2 Global Radiopharmaceuticals Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Radiopharmaceuticals Forecast by Type
11.8 Global Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Information
12.1.2 Radiopharmaceuticals Product Offered
12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging Latest Developments
12.2 Jubilant Pharma
12.2.1 Company Information
12.2.2 Radiopharmaceuticals Product Offered
12.2.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Jubilant Pharma Latest Developments
12.3 Bayer
12.3.1 Company Information
12.3.2 Radiopharmaceuticals Product Offered
12.3.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Nordion
12.4.1 Company Information
12.4.2 Radiopharmaceuticals Product Offered
12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Nordion Latest Developments
12.5 Triad Isotopes
12.5.1 Company Information
12.5.2 Radiopharmaceuticals Product Offered
12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes Latest Developments
12.6 Mallinckrodt
12.6.1 Company Information
12.6.2 Radiopharmaceuticals Product Offered
12.6.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mallinckrodt Latest Developments
12.7 GE Healthcare
12.7.1 Company Information
12.7.2 Radiopharmaceuticals Product Offered
12.7.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 GE Healthcare Latest Developments
12.8 Lantheus
12.8.1 Company Information
12.8.2 Radiopharmaceuticals Product Offered
12.8.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Lantheus Latest Developments
12.9 China Isotope & Radiation
12.9.1 Company Information
12.9.2 Radiopharmaceuticals Product Offered
12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 China Isotope & Radiation Latest Developments
12.10 IBA Group
12.10.1 Company Information
12.10.2 Radiopharmaceuticals Product Offered
12.10.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 IBA Group Latest Developments
12.11 Eli Lilly
12.11.1 Company Information
12.11.2 Radiopharmaceuticals Product Offered
12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eli Lilly Latest Developments
12.12 Dongcheng
12.12.1 Company Information
12.12.2 Radiopharmaceuticals Product Offered
12.12.3 Dongcheng Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Dongcheng Latest Developments
12.13 SIEMENS
12.13.1 Company Information
12.13.2 Radiopharmaceuticals Product Offered
12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 SIEMENS Latest Developments
12.14 Navidea
12.14.1 Company Information
12.14.2 Radiopharmaceuticals Product Offered
12.14.3 Navidea Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Navidea Latest Developments
12.15 Advanced Accelerator Applications
12.15.1 Company Information
12.15.2 Radiopharmaceuticals Product Offered
12.15.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Advanced Accelerator Applications Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Radiopharmaceuticals Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Radiopharmaceuticals Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Radiopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Diagnostic Radioisotopes
Table 7. Major Players of Therapeutic Radioisotopes
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 10. Global Radiopharmaceuticals Revenue by Type (2015-2020) ($ million)
Table 11. Global Radiopharmaceuticals Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Radiopharmaceuticals Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 15. Global Radiopharmaceuticals Value by Application (2015-2020)
Table 16. Global Radiopharmaceuticals Value Market Share by Application (2015-2020)
Table 17. Global Radiopharmaceuticals Sale Price by Application (2015-2020)
Table 18. Global Radiopharmaceuticals Sales by Company (2017-2019) (K Dose)
Table 19. Global Radiopharmaceuticals Sales Market Share by Company (2017-2019)
Table 20. Global Radiopharmaceuticals Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Radiopharmaceuticals Revenue Market Share by Company (2017-2019)
Table 22. Global Radiopharmaceuticals Sale Price by Company (2017-2019)
Table 23. Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Radiopharmaceuticals Products Offered
Table 25. Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Radiopharmaceuticals Consumption by Regions 2015-2020 (K Dose)
Table 27. Global Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Table 28. Global Radiopharmaceuticals Value by Regions 2015-2020 ($ Millions)
Table 29. Global Radiopharmaceuticals Value Market Share by Regions 2015-2020
Table 30. Americas Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 31. Americas Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 32. Americas Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 34. Americas Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 35. Americas Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 36. Americas Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 37. Americas Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 38. APAC Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 39. APAC Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 40. APAC Radiopharmaceuticals Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Radiopharmaceuticals Value Market Share by Regions (2015-2020)
Table 42. APAC Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 43. APAC Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 44. APAC Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 45. APAC Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 46. Europe Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 47. Europe Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 48. Europe Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 50. Europe Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 51. Europe Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 52. Europe Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 53. Europe Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Radiopharmaceuticals Consumption by Countries (2015-2020) (K Dose)
Table 55. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Radiopharmaceuticals Consumption by Type (2015-2020) (K Dose)
Table 59. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Radiopharmaceuticals Consumption by Application (2015-2020) (K Dose)
Table 61. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 62. Radiopharmaceuticals Distributors List
Table 63. Radiopharmaceuticals Customer List
Table 64. Global Radiopharmaceuticals Consumption Forecast by Countries (2021-2025) (K Dose)
Table 65. Global Radiopharmaceuticals Consumption Market Forecast by Regions
Table 66. Global Radiopharmaceuticals Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Radiopharmaceuticals Value Market Share Forecast by Regions
Table 68. Global Radiopharmaceuticals Consumption Forecast by Type (2021-2025) (K Dose)
Table 69. Global Radiopharmaceuticals Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Radiopharmaceuticals Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Radiopharmaceuticals Value Market Share Forecast by Type (2021-2025)
Table 72. Global Radiopharmaceuticals Consumption Forecast by Application (2021-2025) (K Dose)
Table 73. Global Radiopharmaceuticals Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Radiopharmaceuticals Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Radiopharmaceuticals Value Market Share Forecast by Application (2021-2025)
Table 76. Bracco Imaging Product Offered
Table 77. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 78. Bracco Imaging Main Business
Table 79. Bracco Imaging Latest Developments
Table 80. Bracco Imaging Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 81. Jubilant Pharma Product Offered
Table 82. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 83. Jubilant Pharma Main Business
Table 84. Jubilant Pharma Latest Developments
Table 85. Jubilant Pharma Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 86. Bayer Product Offered
Table 87. Bayer Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 88. Bayer Main Business
Table 89. Bayer Latest Developments
Table 90. Bayer Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 91. Nordion Product Offered
Table 92. Nordion Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 93. Nordion Main Business
Table 94. Nordion Latest Developments
Table 95. Nordion Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 96. Triad Isotopes Product Offered
Table 97. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 98. Triad Isotopes Main Business
Table 99. Triad Isotopes Latest Developments
Table 100. Triad Isotopes Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Product Offered
Table 102. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 103. Mallinckrodt Main Business
Table 104. Mallinckrodt Latest Developments
Table 105. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 106. GE Healthcare Product Offered
Table 107. GE Healthcare Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 108. GE Healthcare Main Business
Table 109. GE Healthcare Latest Developments
Table 110. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 111. Lantheus Product Offered
Table 112. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 113. Lantheus Main Business
Table 114. Lantheus Latest Developments
Table 115. Lantheus Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 116. China Isotope & Radiation Product Offered
Table 117. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 118. China Isotope & Radiation Main Business
Table 119. China Isotope & Radiation Latest Developments
Table 120. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 121. IBA Group Product Offered
Table 122. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 123. IBA Group Main Business
Table 124. IBA Group Latest Developments
Table 125. IBA Group Basic Information, Company Total Revenue (in $ million), Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 126. Eli Lilly Product Offered
Table 127. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 128. Eli Lilly Main Business
Table 129. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Eli Lilly Latest Developments
Table 131. Dongcheng Product Offered
Table 132. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 133. Dongcheng Main Business
Table 134. Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Dongcheng Latest Developments
Table 136. SIEMENS Product Offered
Table 137. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 138. SIEMENS Main Business
Table 139. SIEMENS Latest Developments
Table 140. SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Navidea Product Offered
Table 142. Navidea Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 143. Navidea Main Business
Table 144. Navidea Latest Developments
Table 145. Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Advanced Accelerator Applications Product Offered
Table 147. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 148. Advanced Accelerator Applications Main Business
Table 149. Advanced Accelerator Applications Latest Developments
Table 150. Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Radiopharmaceuticals
Figure 2. Radiopharmaceuticals Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Radiopharmaceuticals Consumption Growth Rate 2015-2025 (K Dose)
Figure 5. Global Radiopharmaceuticals Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Diagnostic Radioisotopes
Figure 7. Product Picture of Therapeutic Radioisotopes
Figure 8. Global Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Figure 9. Global Radiopharmaceuticals Value Market Share by Type (2015-2020)
Figure 10. Radiopharmaceuticals Consumed in Oncology
Figure 11. Global Radiopharmaceuticals Market: Oncology (2015-2020) (K Dose)
Figure 12. Global Radiopharmaceuticals Market: Oncology (2015-2020) ($ Millions)
Figure 13. Radiopharmaceuticals Consumed in Cardiology
Figure 14. Global Radiopharmaceuticals Market: Cardiology (2015-2020) (K Dose)
Figure 15. Global Radiopharmaceuticals Market: Cardiology (2015-2020) ($ Millions)
Figure 16. Radiopharmaceuticals Consumed in Other
Figure 17. Global Radiopharmaceuticals Market: Other (2015-2020) (K Dose)
Figure 18. Global Radiopharmaceuticals Market: Other (2015-2020) ($ Millions)
Figure 19. Global Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure 20. Global Radiopharmaceuticals Value Market Share by Application (2015-2020)
Figure 21. Global Radiopharmaceuticals Sales Market Share by Company in 2017
Figure 22. Global Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 23. Global Radiopharmaceuticals Revenue Market Share by Company in 2017
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Company in 2019
Figure 25. Global Radiopharmaceuticals Sale Price by Company in 2019
Figure 26. Global Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Figure 27. Global Radiopharmaceuticals Value Market Share by Regions 2015-2020
Figure 28. Americas Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 29. Americas Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 30. APAC Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 31. APAC Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 32. Europe Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 33. Europe Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Radiopharmaceuticals Consumption 2015-2020 (K Dose)
Figure 35. Middle East & Africa Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 36. Americas Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 37. Americas Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 38. Americas Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 39. Americas Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 40. United States Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 41. United States Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 43. Canada Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 45. Mexico Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 47. APAC Radiopharmaceuticals Value Market Share by Regions in 2019
Figure 48. APAC Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 49. APAC Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 50. China Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 51. China Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 53. Japan Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 55. Korea Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 57. Southeast Asia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 58. India Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 59. India Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 61. Australia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 63. Europe Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 64. Europe Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 65. Europe Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 66. Germany Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 67. Germany Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 68. France Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 69. France Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 70. UK Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 71. UK Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 73. Italy Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 75. Russia Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 80. Egypt Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 81. Egypt Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 83. South Africa Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 85. Israel Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 87. Turkey Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Radiopharmaceuticals Consumption Growth 2015-2020 (K Dose)
Figure 89. GCC Countries Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 90. Global Radiopharmaceuticals Consumption Growth Rate Forecast (2021-2025) (K Dose)
Figure 91. Global Radiopharmaceuticals Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 93. Americas Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 94. APAC Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 95. APAC Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 96. Europe Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 97. Europe Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 99. Middle East & Africa Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 100. United States Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 101. United States Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 102. Canada Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 103. Canada Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 104. Mexico Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 105. Mexico Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 106. Brazil Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 107. Brazil Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 108. China Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 109. China Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 110. Japan Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 111. Japan Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 112. Korea Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 113. Korea Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 115. Southeast Asia Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 116. India Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 117. India Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 118. Australia Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 119. Australia Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 120. Germany Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 121. Germany Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 122. France Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 123. France Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 124. UK Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 125. UK Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 126. Italy Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 127. Italy Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 128. Russia Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 129. Russia Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 130. Spain Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 131. Spain Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 132. Egypt Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 133. Egypt Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 134. South Africa Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 135. South Africa Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 136. Israel Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 137. Israel Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 138. Turkey Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 139. Turkey Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Radiopharmaceuticals Consumption 2021-2025 (K Dose)
Figure 141. GCC Countries Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 142. Bracco Imaging Radiopharmaceuticals Market Share (2018-2020)
Figure 143. Jubilant Pharma Radiopharmaceuticals Market Share (2018-2020)
Figure 144. Bayer Radiopharmaceuticals Market Share (2018-2020)
Figure 145. Nordion Radiopharmaceuticals Market Share (2018-2020)
Figure 146. Triad Isotopes Radiopharmaceuticals Market Share (2018-2020)
Figure 147. Mallinckrodt Radiopharmaceuticals Market Share (2018-2020)
Figure 148. GE Healthcare Radiopharmaceuticals Market Share (2018-2020)
Figure 149. Lantheus Radiopharmaceuticals Market Share (2018-2020)
Figure 150. China Isotope & Radiation Radiopharmaceuticals Market Share (2018-2020)
Figure 151. IBA Group Radiopharmaceuticals Market Share (2018-2020)
Figure 152. Eli Lilly Radiopharmaceuticals Market Share (2018-2020)
Figure 153. Dongcheng Radiopharmaceuticals Market Share (2018-2020)
Figure 154. SIEMENS Radiopharmaceuticals Market Share (2018-2020)
Figure 155. Navidea Radiopharmaceuticals Market Share (2018-2020)
Figure 156. Advanced Accelerator Applications Radiopharmaceuticals Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets